Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
FBRX holding history
Forte Biosciences, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FBRX overviewAll 13F holders of FBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,972
- Value
- $445.7K
- % of portfolio
- 0.1%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,972 | $445.7K | 0.1% | −98,000−82.4% | Reduced | Holders |
| Q1 2026 | 118,972 | $3.08M | 0.4% | −181,028−60.3% | Reduced | Holders |
| Q4 2025 | 300,000 | $8.18M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 300,000 | $4.50M | 1.0% | −176,443−37.0% | Reduced | Holders |
| Q2 2025 | 476,443 | $6.16M | 2.0% | −132,782−21.8% | Reduced | Holders |
| Q1 2025 | 609,225 | $4.73M | 1.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 609,225 | $13.8M | 4.0% | +609,225 | New | Holders |